A61K 38/2221
Relaxins
Official title: {Relaxins}
A61K38/2221 (Relaxins) appears on 94 US grants and 172 published applications in this corpus.
Search patents in A61K- Granted patents
- 94
- Published applications
- 172
- Assignees
- 78
- Inventors
- 263
- Latest grant
- 4 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 1 |
| 2002 | 1 | 5 |
| 2003 | 0 | 0 |
| 2004 | 4 | 4 |
| 2005 | 0 | 8 |
| 2006 | 2 | 8 |
| 2007 | 0 | 1 |
| 2008 | 0 | 6 |
| 2009 | 1 | 4 |
| 2010 | 2 | 6 |
| 2011 | 4 | 9 |
| 2012 | 1 | 4 |
| 2013 | 4 | 8 |
| 2014 | 3 | 12 |
| 2015 | 3 | 7 |
| 2016 | 3 | 9 |
| 2017 | 6 | 13 |
| 2018 | 4 | 7 |
| 2019 | 8 | 13 |
| 2020 | 8 | 4 |
| 2021 | 3 | 7 |
| 2022 | 8 | 9 |
| 2023 | 7 | 7 |
| 2024 | 3 | 11 |
| 2025 | 3 | 8 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Synthetic cellular signaling pathways and uses thereof4 Mar 2025US 12,239,718 B2Trustees of Boston University
- Medical composition for treating cardiac wasting and cachexia18 Feb 2025US 12,226,455 B2RELAXERA Pharmazeutische GmbH & Co. KG
- Heterodimeric Relaxin fusions and uses thereof7 Jan 2025US 12,187,774 B2MedImmune, LLC
- Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptides24 Sep 2024US 12,097,241 B2Bristol-Myers Squibb Company
- Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptides24 Sep 2024US 12,097,242 B2Bristol-Myers Squibb Company
- Pharmaceutical formulation comprising heterodimeric relaxin fusion proteins and uses thereof20 Aug 2026US 2026/0240953 A1AstraZeneca AB
- Fusion protein of relaxin or analogue and medical use thereof9 Oct 2025US 2025/0312444 A1Beijing Tuo Jie Biopharmaceutical Co. Ltd.
- Treatment Using Heterodimeric Relaxin Fusions25 Sep 2025US 2025/0295737 A1MedImmune, LLC
- Inhalable porous microsphere loaded with recombinant human relaxin-2 and preparation method therefor24 Jul 2025US 2025/0235507 A1Shandong University
- Heterodimeric relaxin fusions and uses thereof17 Jul 2025US 2025/0230214 A1MedImmune, LLC
Most cited
By later US patents
- Methods for enabling and stabilizing tooth movement83US 6,984,128 B2BAS Medical, Inc. · 2006
- Method of treating myofascial pain syndrome with relaxin80US 5,863,552 A1999
- Reconstitutable lyophilized protein formulation63US 5,192,743 AGenentech, Inc. · 1993
- Treatment of conditions through modulation of the autonomic nervous system during at least one predetermined menstrual cycle phase63US 7,899,527 B2Palo Alto Investors · 2011
- Use of relaxin in the treatment of bradycardia55US 5,478,807 AGenentech, Inc. · 1995